Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717275 · ClinicalTrials.gov registry record · Phase 2
Study of Temozolomide to Treat Newly Diagnosed Brain Metastases
A Phase 2 study, sponsored by University of Florida.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00717275 is a Phase 2 study that was terminated before completion, run by University of Florida. The registered enrollment target is 3 participants.
The verdict
NCT00717275, a Phase 2 study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if administering temozolomide after completion of stereotactic radiosurgery helps control existing brain metastases and prevents the developement of new brain metastases.
Interventions
- DRUG Temozolomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00717275
The ClinicalTrials.gov registry entry for NCT00717275 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Temozolomide is the first listed.
NCT00717275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00717275 about?
NCT00717275 is a clinical study titled "Study of Temozolomide to Treat Newly Diagnosed Brain Metastases". The purpose of this study is to determine if administering temozolomide after completion of stereotactic radiosurgery helps control existing brain metastases and prevents the developement of new brain metastases.
What is the current status of trial NCT00717275?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2008-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00717275?
The interventions under investigation include: Temozolomide (DRUG).
Who is sponsoring clinical trial NCT00717275?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.